Leadership & Management
Entrepreneurial leadership, breaking new barriers

Leadership & Management: Welcome to Health Industry Hub’s Women in Leadership Series – connecting, engaging and empowering women in the Pharma, MedTech and Biotech sectors by celebrating and sharing the journey of inspirational and passionate women leaders in the industry.
Lauren Barber, an experienced nurse and entrepreneur, recently launched a novel medtech to ‘close the gate’ on vaccinations. The technology is a game-changer and can be used in an estimated 76 million needle procedures in Australia each year.
In this episode, we dive into the two critical traits empowering women on their leadership journey, the most defining moment in Lauren’s leadership journey, overcoming the fear factor, and more.
As the past Chair of Medical Technology Association of Australia (MTAA) Women in MedTech committee, Lauren also addressees the gender pay gap raised in a recent report.
Podcast
About Lauren Barber
Lauren Barber is a Clinical Nurse Specialist with post graduate qualifications in Healthcare Leadership and Cosmetic Dermatology. Throughout her nursing career Lauren has held various leadership and management roles including clinical supervision and nurse unit manager.
As an entrepreneur, Lauren is the founder and managing director of start-up medical device company NeedleCalm Pty Ltd. She divides her time between developing and commercialising an innovative medical device with leadership roles with the Medical Technology Association of Australia as both previously a Board Member and Chair of the Women in MedTech Committee.
Earlier in her career whilst nursing in emergency departments, Lauren saw the effects that the fear and phobia of needles had on patients and staff and the consequences of healthcare avoidance. This led her to develop a technique of injection to reduce the pain and discomfort associated with needle-related procedures. Since 2016 Lauren has worked to transfer this method of injection into a product, recently launched, for use in patients around the world.
News - Pharmaceuticals
New vaccine guidelines risk further decline in immunisation
The intensifying political and public scrutiny of Dr Anthony Fauci has become emblematic of a wider struggle over trust in […]
MoreNews - Pharmaceuticals
The weight of the wait: GLP-1 boom hits PBS roadblock
More than one million Australians have been dispensed a GLP-1 receptor agonist over the past five years, accelerating the emergence […]
MoreNews - MedTech & Diagnostics
As insurer blame game escalates, patients miss out on the promise of private health
The Age and Sydney Morning Herald’s investigation into the Prescribed List (PL) and the pricing of medical devices has drawn […]
MoreLeadership & Management
David Henderson appointed Takeda Oceania Country Head
David Henderson has been appointed Country Head for Takeda Oceania, succeeding Dave Pearce, as the pharmaceutical company continues to reshape […]
More